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Abstract The objective of this work was to evaluate the
prevalence of sensorineural hearing loss (SNHL) and distri-
bution of the main risk factors associated to it focusing on
their role in the development of deafness and their interaction.
We performed a global audiological assessment (through
TEOAE, tympanometry and ABR) in 508 infants at risk
studying the main risk factors reported by Joint Committee on
Infant Hearing (2007). Fifty-one infants (10.03 %) were
diagnosed with SNHL (45 bilateral and 6 unilateral) with a
mean hearing threshold of 87.39 ± 28.25 dB HL; family
history of hearing impairment (HI) and TORCH infections
indicated independent significant risk factors (P \ 0.00001
and P = 0.024, respectively). High SNHL percentages were
evidenced also in NICU babies, due to the various pathologies
and risk factors presented by these infants, and among new-
borns who suffered from hyperbilirubinemia (11.97 and
9.52 %, respectively). The mean degree of hearing loss for
children with family history of HI ([100 dB HL) emphasizes
the necessity of an early diagnosis to avoid the consequences
of auditory deprivation. Craniofacial abnormalities and
syndromes associated to HI showed an important relationship
(P \ 0.00001) with conductive hearing loss. A progressive
increase was evidenced in SNHL incidence as the number of
risk factors rises (from 5.12 for 2 risk factors to 28.5 % for 5
or more) with a significant difference among the groups
(P = 0.049); multiple risk factors showed an additional
cofactor for HL (r2 = 0.93). Considering the high SNHL
prevalence (10.03 %) in infants at risk, this study highlights
the necessity to implement a neonatal hearing screening
program in Western Sicily.
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Introduction
Among congenital anomalies, sensorineural hearing loss
(SNHL) represents a condition occurring in 1–2 infants
every 1,000 births [1, 2], with a prevalence increasing from
10- to 50-fold in certain higher risk populations (for
example, NICU babies). Comparing SNHL incidence with
that of other congenital pathologies routinely screened at
birth like phenylketonuria (1:15,000 newborns) and hypo-
thyroidism (1:4,500 newborns), permanent hearing loss
appears more frequent. In comparison to children with
normal hearing, those with hearing loss experience more
difficulties developing verbal skills (learning vocabulary,
grammar, word order and idiomatic expressions), language,
learning and speech. Hearing impairment influences also
cognitive and affective development of infants making
consequences in their interpersonal relationships [3, 4].
Thus, it is necessary to promote a system of prevention
to detect hearing impairment in the first months of life.
This objective can be reached by implementing a neonatal
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audiological screening extended to the entire population or
at least to infants at risk. Specifically, Joint Committee on
Infant Hearing (JCIH) in the Position Statement of 2007 [5]
reported risk factors associated with hearing loss (JCIH
2007), expanding those presented in older risk registries
[6]. Although a family history of hearing loss (syndromic
or non-syndromic), cranio-facial abnormalities, prenatal
infections (TORCH), hyperbilirubinemia requiring
exchange transfusion, and culture-positive sepsis were
previously reported, other independent neonatal risk factors
have been included. These risk factors include a need for
ventilation, use of oxygen supplementation, respiratory
failure, low Apgar scores, acidosis, use of ototoxic drugs
including furosemide (especially with high serum creati-
nine levels), treatment for hypotension, patent ductus
arteriosus ligation, hyponatremia, and noise [7–14]. Inter-
action among risk factors has been evidenced [12].
Despite a large diffusion of newborn hearing screening
(NHS) in most parts of the developed world as an essential
instrument of neonatal care, in Italy there is no stipulated
modality to reach the objective of SNHL early detection in
individual regions. So an early diagnosis is made possible
only by the initiatives taken by hospitals that have acti-
vated local programs based on the collaboration of the
single birth centers and the Audiology Sections. This
reality leads to a high percentage of undiscovered perma-
nent hearing loss (*30 %) with a medical diagnosis made
in 30–40 % of cases after sixth month of age.
The main purpose of this study was to evaluate the
prevalence of SNHL on infants at risk in Western Sicily;
additional goals were to describe the distribution of risk
factors associated with SNHL analyzing their role in the
development of deafness and the effects of their interac-
tion, underling the importance of a suitable and adequate
hearing assessment especially for those populations at risk
for permanent hearing impairment.
Materials and methods
This study was carried out by Department of Audiology,
University of Palermo, examining all the infants, trans-
ferred from the eight births centers of Western Sicily for
the presence of risk indicators associated with permanent
congenital, delayed-onset, or progressive hearing loss from
January 2010 to December 2011; the subject group con-
sisted of 527 infants, 298 males and 229 females, ranging
from 4 to 20 weeks of life at the moment of the first
appointment. After ethical Committee approval, the study
protocol was fully explained to patients or their guardians,
and written informed consent was obtained from each
patient. Out of 527 patients, 519 (98.48 %) accepted to
participate in this study but 11 infants were lost to follow-
up monitoring. The final response rate was 96.39 % cor-
responding to 508 infants. Through the discharge letter
released by the birth centers and through a questionnaire
answered by the parents, the following risk factors were
researched, making a distinction between prenatal and
perinatal risk factors (JCIH): in the first group, family
history of permanent childhood hearing impairment, con-
sanguinity, pregnant maternal infection (TORCH) and
drugs exposition during pregnancy; in the second group,
premature birth (gestational age B37 weeks), intensive
care in excess of 5 days, respiratory distress (IRDS),
hyperbilirubinemia requiring exchange transfusion, very
low birth weight (\1,500 g, VLBW), cranio-facial abnor-
mality (CFA) and syndromes associated to HI, perinatal
infections like sepsis and meningitis, ototoxic drugs
administration (furosemide, dexamethasone, vancomycin,
gentamycin and tobramycin), acidosis, hyponatremia, head
trauma.
An experienced audiologist and otorhinolaryngologist
examined the condition of the external auditory canal and
tympanic membrane with otoscopy, and nose, throat, head
and face in search of ear anomalies and syndromic features
related to hearing impairment.
The audiologic assessment was performed by the same
qualified bio-medical staff and consisted of ABR, TEOAE
and tympanometry measurement. ABR measurements were
recorded in a soundproof room; all children were in natural
sleep or in calm conditions throughout the assessment.
Both ears were sequentially tested. AMPLAID mk22
auditory evoked potentials system was used for testing the
infants. After adequate preparation of skin, recording silver
electrodes were attached to upper forehead (recording
electrode), the ipsilateral mastoid process (reference elec-
trode) and contralateral mastoid process (ground elec-
trode). Thus, the Fpz-M1-M2 electrode montage was used
for recording the ABR. The acoustic stimuli consisted of
unfiltered full square wave pulses of 100 ls duration and
with alternating polarity. The clicks were delivered mon-
aurally by a hand held TDH-49 headphone, at a rate of
21 s-1. The analysis time was 15 ms. The recording
bandwidth for click threshold determination was
100–2,500 Hz. The electrode and interelectrode impedance
were insured to be below 5 and 2 kX, respectively. Each
run consisted of summing the responses to 2,000 clicks.
Click stimuli were presented starting at a level of 100 dB
HL. With step sizes of 10 dB, the level was decreased until
no response was found. The response threshold was esti-
mated by the lowest level at which a response was found.
An infant was considered to have passed the ABR test if a
replicable wave V response was present at 30 dB HL in
both ears, while SNHL was defined as elevated ABR
response thresholds (C40 dB) in one or both ears. More-
over, the absolute latencies and interpeak intervals as well
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as the response thresholds were analyzed. Experienced
clinical specialists interpreted the ABR response waves.
The response latencies in milliseconds were obtained by
establishing the peak of the wave and reading out the
digitally displayed time. From the latency intensity curves,
the level of conductive hearing loss was estimated
(increase of overall waves absolute latencies without in-
terpeak intervals modification). This has been described in
the literature as a valid method to identify a conductive
hearing loss [15]. TEOAE and tympanometry measurement
were used to confirm the diagnosis of conductive hearing
loss when available. In particular, the first one was per-
formed using the Otodynamics ILO 288 USB II system
with the standard settings; the stimulus level was set to
84 dB SPL, a number of 260 averages was used. Tympa-
nometry was performed with an Interacoustics AT 235H
system using the standard settings and a 1-kHz probe
frequency and an air pressure range of -400 to
-100 mmH2O with automatic recording.
The parents of an infant with suspicion of hearing
impairment were informed of the results of the initial test
and received recommendations to return for a follow-up
evaluation after 3 weeks. Statistical analysis was con-
ducted with Matlab computer programme; v2 test, odds
ratio (OR) and/or exact test of Fisher test were used, fol-
lowing usual conditions of application. Significance was
set at 0.05.
Result
Between January 2010 and December 2011, 508 infants at
risk, ranged from 4 to 20 weeks of life, were examined at
our department. Of the newborns, 214 were female
(42.13 %) and 294 were male (57.87 %) with a male:
female ratio = 1.37.
Audiologic evaluation revealed the presence of hearing
loss in 97 children (56 males and 41 females) and identified
CHL in 46 infants (9.05 %) and SNHL in 51 children
corresponding to 10.03 % of the study group (32 males and
19 females, with a male:female ratio = 1.68). There is no
statistically significant difference in prevalence of SNHL
among sex (v2 = 0.55, P = 0.45, OR = 1.25). Out of 51
SNHL infants, 45 subjects (88.23 %) were diagnosed with
bilateral SNHL; a symmetric HL, defined by an inter-aural
threshold difference \30 dB, was evidenced in the
91.11 % corresponding to 41 cases (80.39 % of the total
infants suffering from SNHL), while in the 8.89 % corre-
sponding to 4 cases, this SNHL was asymmetric (inter-
aural threshold difference C30 dB). Finally, 6 infants
(11.76 %) were affected by unilateral SNHL, with a
response threshold in the best hearing ear B40 dB. Among
the total ears suffering from SNHL, our study evidenced an
hearing threshold mean value of 88.47 ± 28.28 dB HL
(median 100 dB HL) for the left ears, of 86.4 ± 28.48 dB
HL (median 100 dB HL) for the right ears, of
87.39 ± 28.25 dB HL (median 100 dB HL) for both ears
without any difference between left and right ears
(t = 0.35, f.d. = 94, P = 0.72).
Of the total infants, 264 (51.96 %) presented one risk
factor, while 244 (48.04 %) were exposed to multiple risk
factors; specifically, 156 cases (30.71 %) were showed 2
risk factors, 62 infants (12.2 %) had 3 risk factors, 19
children (3.74 %) were affected by 4 risk factors and finally
only 7 newborns (1.37 %) showed 5 or more risk factors.
Prevalence of prenatal risk factors (143 subjects corre-
sponding to 27.14 %) was lower than that of perinatal risk
factors (385 infants corresponding to 75.78 %) with a
perinatal:prenatal ratio = 2.69 (Table 1).
In the first group, 57 infants (39.86 %) had a familiar
history of HI, 46 newborns (32.16 %) suffered from
TORCH infections and 47 infants (32.86 %) were exposed
to drugs during pregnancy.
In the second group that includes risk factors occurring
from birth to the 28th day of life, prematurity, intensive
care in excess of 5 days and respiratory distress showed the
highest prevalence, with 191 infants born preterm
(49.61 %), 142 admitted to NICU (36.88 %) and 139 that
suffered from IRDS (36.1 %). Lower percentage concerned
other risk factors like hyperbilirubinemia requiring photo-
therapy, found in 63 newborns (16.36 %), VLBW, that
regarded 48 infants (12.46 %), syndromes associated with
HI and cranio-facial anomalies (CFA) which affected 71
children (18.44 %). Finally, 30 infants (7.79 %) suffered
from perinatal infections (like sepsis and meningitis) with
the administration of ototoxic antibiotics in 27 newborns
(7.01 %); only 2 cases with head trauma were found
(0.52 %). Figure 1 shows the SNHL prevalence relative to
each group.
The univariate analysis showed a statistically significant
correlation between a familiar history of HI and SNHL
(v2 = 32.98, P \ 0.00001, OR = 5.85) with an SNHL
prevalence respectively of 31.57 and 7.31 % for infants
with and without this risk factor. Moreover, our study
evidenced an important difference (t = 3.63, f.d. = 49,
P = 0.0007) from the comparison of mean hearing
threshold of SNHL newborns with family history of HI
([100 dB HL) and SNHL newborns exposed to other risk
factors (75.75 ± 28.58 dB HL).
TORCH agents was showed to be an important predictor
of SNHL (v2 = 5.08, P = 0.024, OR = 2.49); infants that
suffered from TORCH infections had greater SNHL
prevalence when compared to children with other risk
factors (19.56 vs. 9.09 %). Of the 9 SNHL newborns
positive to TORCH agents, 5 (55.55 %) were affected by
cytomegalovirus (CMV) infection.
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Drugs administration in pregnancy demonstrated no
statistically significant influence on SNHL; indeed of the
47 children presenting this risk factor, only one infant
(2.12 %) developed SNHL.
The role of prematurity as risk factor for SNHL was also
assessed; children who were preterm had a lower SNHL
rates when compared to those exposed to other risk factors
(5.75 vs. 12.61 %), with a statistically significant differ-
ence (v2 = 6.21, P = 0.012). The mean gestational age
study between NHL and SNHL preterm infants showed no
significant differences among the subjects (mean
weeks = 33.2 ± 3.1 for NHL and 32.2 ± 4.5 for SNHL
infants with t = 1.039, P = 0.299), even if with P = 0.045
statistical analysis revealed a higher percentage of SNHL
in children born before the 30th week than those preterm
who born after 30th week.
Nevertheless, a high prevalence of SNHL among NICU
babies (11.97 %), we did not find any difference between
newborns admitted to NICU for more than 5 days and
those exposed to other risk factors. An infant staying alive
Table 1 Distribution, Chi-square, odds ratio, 95 % CI and hearing threshold mean values relative to prenatal and perinatal risk factors of total
infants
Risk factor No. of infant (508)
N (%)
SNHL (51) No./total
group (%)
v2 P OR 95 % CI Mean hearing threshold
(dB HL)
Prenatal
Family history of HI 57 (11.2) 18 (35.29) 32.98 \0.00001 5.85 3.02–11.33 [100
TORCH 46 (9.05) 9 (17.64) 5.08 0.024 2.49 1.10–5.38 67.2
Drugs administration in
pregnancy
47 (9.25) 1 (9.26) 0.71 50
Perinatal
Prematurity 191 (37.59) 11 (21.56) 6.21 0.0127 0.42 0.21–0.85 75.54
NICU 142 (27.95) 17 (33.33) 0.81 0.36 1.33 0.72–2.46 79.41
IRDS 139 (27.36) 10 (19.6) 1.71 0.19 0.62 0.3–1.27 89
Hyperbilirubinemia 63 (12.4) 6 (11.76) 0.02 0.88 0.94 0.38–2.29 72.5
VLBW 48 (9.44) 4 (7.84) 1 90
CFA and syndromes
associated to HI
71 (13.97) 5 (9.8) 0.82 0.36 0.64 0.25–1.68 72
Perinatal infections 30 (5.9) 1 (1.96) 0.344 [100
Ototoxic drugs 27 (5.31) 3 (5.88) 0.745 [100
Head trauma 2 (0.39) 0 (0) /
IRDS respiratory distress, VLBW very low birth weight, CFA cranio-facial abnormality
19,56% 2,12% 5,75% 11,97% 7,19% 9,52% 8,33% 7,04% 3,33% 11,11% 0,00%
0%
100%
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Fig. 1 Prevalence of SNHL for
single prenatal and perinatal
risk factor
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in NICU has a 33 % greater chance of developing SNHL
compared with others newborns, but the relation is not
statistically significant (v2 = 0.81, P = 0.36, OR = 1.33).
A detailed analysis of characteristics of NICU newborns is
shown in Table 2.
According to Table 1, among infants that suffered from
IRDS and hyperbilirubinemia, we evidenced an incidence
of SNHL of 7.19 % (v2 = 1.71, P = 0.19, OR = 0.62) and
9.52 %, respectively (v2 = 0.02, P = 0.88, OR = 0.84);
furthermore, there is no difference between newborns with
VLBW and those without (P = 1). Among SNHL children
with VLBW (4/48 corresponding to 8.33 % of the group), a
significant difference was evidenced between infants who
had a birth weight\1,000 g (3 cases of 4 with SNHL) and
those who weighed C1,000 g (P = 0.017); furthermore,
the mean weight calculated for SNHL infants was
950 ± 40.82 g instead of 1,193.04 ± 236.94 g for NHL
newborns (t = 2.02, f.d. = 46, P = 0.048).
CFA and syndromes associated to HI were studied and
no statistically significant relationship with SNHL was
found (v2 = 0.82, P = 0.36, OR = 0.64). However, we
evidenced higher percentage of CHL (54.34 %) in new-
borns that presented CFA or syndromes associated with
SNHL (v2 = 68.57, P \ 0.00001).
Finally, a prevalence of SNHL of 3.33, 11.11 and 0 %
was found in newborns with perinatal infections, admin-
istration of ototoxic antibiotics and head trauma, respec-
tively. No statistically significant relationship with SNHL
was found.
The analysis of the auditory deficit for infants presenting
two or more risk factors showed significant statistical dif-
ference in prevalence of SNHL among the groups
(v2 = 7.84, P = 0.049, fd = 3). In fact, we evidenced an
incidence of SNHL of 5.12 % (OR = 0.61) in newborns
with two audiological risk factors, of 7.69 % (OR = 1.09)
for three risk factors, of 15.78 % (OR = 2.56) for four risk
factors and of 28.5 % (OR = 5.44) in case of five or more
risk factors (mean hearing threshold values of 76.25 ±
28.5 dB HL, 72.5 ± 33.04 dB HL, 96.66 ± 40.41 dB HL,
85 ± 49.49 dB HL, respectively). The study of mean hear-
ing threshold for each risk factor is reported in Table 1.
Discussion
Actually, in Italy, the absence of a unique stipulated
modality for an early detection of HI (extended to the
entire country) makes more ineffective the identification of
deafness in the early childhood with a certain number of
SNHL remaining undiscovered or diagnosed after 6th
month of age. In fact, the NHS coverage percentage ranges
from 79.5 % for the North-West Italy, corresponding to the
most economically developed areas, to 11.3 % for the
Islands like Sicily where the initiatives are still left to
individual hospitals (often without qualified instrumenta-
tion and specialized medical staff) [16–18].
The aim of our report was to study, through a global
audiologic evaluation, the SNHL prevalence and the dis-
tribution of the main risk factors for permanent congenital,
delayed-onset, or progressive hearing loss (identified by
JCIH 2007) and their correlation with SNHL, among a
cohort of 508 infants at risk, who were transferred to the
only tertiary Speech and Hearing Center of Western Sicily,
from all the birth centers that decided to participate in the
study from January 2010 to December 2011.
In fact, according to literature, the identification inside
a population of the cause of the hearing loss provides
new information relevant to hearing loss management,
Table 2 Analysis of risk factors for SNHL among NICU newborns: logistic regression analysis, correlation coefficient b, P value, odds ratio and
95 % confidence limits
Risk factor NHL (125)
N (%)
SNHL (17)
N (%)
Odds ratio (OR, partial logistic regression
coefficient b)
P value 95 % CI
Family history of HI 1 (0.8) 1 (5.88) 7.75 (2.04) 0.15 0.46–130.06
TORCH 3 (2.4) 2 (11.76) 5.42 (1.69) 0.076 0.837–35.1
Drugs administration in
pregnancy
8 (6.4) 1 (5.88) 0.805 (-0.21) 0.84 0.09–6.78
Prematurity 36 (28.8) 7 (41.17) 2.03 (0.71) 0.018 0.71–5.79
IRDS 60 (48) 10 (58.82) 2.07 (0.72) 0.16 0.74–5.8
Hyperbilirubinemia 19 (15.2) 6 (35.29) 3.58 (1.27) 0.035 1.09–11.81
VLBW 24 (19.2) 4 (23.52) 1.29 (0.25) 0.67 0.38–4.32
Perinatal infections 17 (13.6) 1 (5.88) 0.58 (-0.53) 0.62 0.07–4.83
Ototoxic drugs 18 (14.4) 2 (11.76) 0.53 (-0.61) 0.56 0.065–4.39
CFA and syndromes associated
to HI
11 (8.8) 0 (0) / / /
IRDS Respiratory distress, VLBW very low birth weight, CFA cranio-facial abnormality
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coexisting medical problems, and the prognosis for the
child and family. In addition, our study could clarify the
epidemiological features of congenital deafness, facilitat-
ing the planning of effective hearing loss prevention and
future surveillance programs in Sicily.
Using as criteria of inclusion the presence of hearing
threshold C40 dB HL in at least one ear, 51 subjects
(10.03 % of the total infants studied) were identified with
SNHL; our study showed a higher SNHL percentage when
compared with those reported by Ohl et al. (4.55 %),
Meyer et al. (5.3 %), Robertson et al. (3.1 %) and Elahi
et al. (7.9 %) [19–22]. The variability in incidence of
SNHL is explicable analyzing the heterogeneous distribu-
tion of risk factors among the cohort studied and the cri-
teria (like hearing threshold) applied to make diagnosis of
SNHL. Specifically, our incidence value is higher because
a large percentage of infants included in the study has a
family history of SNHL. In fact, in our cohort, the SNHL
prevalence was 7.31 % (33/451) excluding ‘family history
of HI’ group, while it was 6.27 % (28/446) and 5.85 % in
case of bilateral SNHL and in case of bilateral SNHL with
hearing threshold C50 dB HL for the best ear, respectively.
The study of distribution of risk factors among Western
Sicily cohort evidenced, as stated above, a high incidence
(57/508, 11.22 %) of a family history of HI, probably due
to the great number of marriages between consanguineous
occurring in the past years [23]. Of them, 18 (31.57 %)
presented SNHL (v2 = 32.98, P \ 0.00001), with a mean
hearing threshold of[100 dB HL (in the 77.77 % of cases,
the hearing loss was profound). This little variability in
degree of SNHL revealed by our report may appear to be
markedly in contrast with that reported by Picciotti et al.
[24] but, as explained by these authors, the variable phe-
notype should be attributed to ethnic diversity in expres-
sion of the gene associated with SNHL, to the presence of
coexisting mutations regarding different genes correlated
with SNHL and to the influence of environmental factors.
However, analyzing the degree of hearing loss of cases
belonging to the Southern Italy and with a family history of
HI, we observed, in line with our results, a mean hearing
threshold of 102.81 ± 21.27.
The preeminent role of family history in the develop-
ment of deafness was hypothesized by Meyer et al. [20],
who also defined this condition as independent risk factor;
it was subsequently underlined by Fortnum [1] and
Jakubı´kova´ et al. [25], and supported by our findings
(P \ 0.00001, OR = 5.85).
Another statistically significant prenatal risk factors
revealed by our analysis were TORCH agents; although
with 46/508 cases TORCH infections are little represented
in our cohort, probably due to good systems of prevention
like rubella vaccine, they are strongly associated with
SNHL (v2 = 5.08, P = 0.024, OR = 2.49); according to
literature data [5, 25–27], even our study empathizes the
role of CMV among TORCH agents and in the develop-
ment of SNHL. Particularly, of the 46 newborns suffering
from TORCH infections, 25 (54.34 %) were positive to
CMV, 8 to Rubella (17.39 %) and 13 (28.26 %) to Toxo-
plasmosis; moreover, even if a significant difference
among the subgroups (v2 = 2.8, P = 0.246, f.d. = 2) was
not found, with a percentage value of 55.55 % of SNHL
infants (corresponding to 5/9 subjects), the CMV infection
was the main cause of deafness among TORCH agents,
while in 3 cases (33.33 %), the Rubella cause was evi-
denced and in only 1 infant (11.11 %), Toxoplasmosis was
diagnosed. Considering SNHL infants positive to CMV
infections, our study revealed an hearing loss from mod-
erate to profound, with a mean hearing threshold of
76 ± 20.43 dB HL, not very different than those reported
by Madden et al. [28] and Mussi-Pinhata et al. [29].
Literature data report that more than 30 % of infants
with SNHL were recovered in NICU [30–35]. In 33.33 %
(17/51) of infants with this risk factor among SNHL
newborns, even our report shows that NICU increases
slightly the probability to be hearing impaired
(OR = 1.33). It is also evidenced by ANOVA test (Fig. 2).
With a prevalence rate of 11.97 % of SNHL NICU babies,
our percentage is higher than those reported by Coenrad
et al. (1.39 %), Hille et al. (3.1 %) and Robertson et al.
(3.2 %) and inferior to those evidenced by Davis and
Parving (32.8 %), Shiu et al. (30.9 %) and Pitt (32 %) [14,
21, 31, 33, 35, 36]. According to Dauman et al. [37], the
high variability in incidence of SNHL among newborns
admitted to NICU reflects a heterogeneous distribution of
different neonatal risk factors more or less involved in the
development of SNHL. In addition, another consideration
should be made for NICU babies: these newborns, in fact,
present often multiple risk factors, a condition that
increases the probability of hearing impairment. Table 2
reports logistic regression analysis for each risk factors in
our NICU cohort; results of a simultaneous multiple
regression analysis of the variation in SNHL prevalence
among NICU infants demonstrated that the relative risk for
SNHL increases by 21.24 % in preterm infants and by
19.33 % in newborns who suffered from hyperbilirubine-
mia when respiratory distress is concomitant with these
risk factors. Furthermore, in this cohort, we observed a
higher risk of SNHL (99.66 %) in case of coexistence of
prematurity and hyperbilirubinemia.
Our study also underlined the role of gestational age and
birth weight as risk factors for SNHL; specifically, among
the 191 preterm infants, 29 (15.18 %) presented extreme
prematurity and of them 4 (corresponding to 13.79 % sub-
jects) were hearing impaired (P = 0.045). Among new-
borns with very low birth weight, a statistically difference
was evidenced between infants with weight \1,000 g and
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those who weighed at birth C1,000 g; in fact, the SNHL
prevalence percentages inside the groups resulted in 8.33,
2.56 and 33.33 % for the total infants with VLBW, for
newborns weighed between 1,000 and 1,500 g and for
children with extremely low birth weight (\1,000 g),
respectively (P = 0.017). These findings are explainable
considering that the greater the severity of prematurity and
the lower the birth weight, more probable is the coexistence
of condition like severe birth asphyxia or assisted ventila-
tion for C5 days that increase the risk of SNHL [12, 38].
The association of two or more risk factors, found in
48.03 % of our infants cohort, also appeared to be an
additional risk for SNHL. As reported by Ohl et al. [19]
and Bielecki et al. [39], our study evidenced a progressive
increase in prevalence of SNHL as the number of risk
factors rose; in fact, in children with two to six coexisting
risk factors the probability of SNHL ranges from 5.16 to
28.5 % (r2 = 0.93).
Finally, concerning the group with CFA and syndromes
associated with HI, as shown in Table 1, no difference was
evidenced between SNHL and the NHL infants, whereas
the same subjects were shown to be more susceptible to
develop CHL (v2 = 68.57, P \ 0.00001). It is explainable
considering that most of the 71 infants presented cleft
palate (16.9 %) or Down syndrome (38.02 %), two con-
ditions often associated with middle ear effusion, upper
airway infections with consequent CHL [40–43].
Conclusion
This report shows that 10.03 % of infants at risk in Western
Sicily suffer from SNHL; with a mean hearing threshold of
87.39 ± 28.25 dB HL (median 100 dB HL), it underlines
the necessity of an early diagnosis before the 6th month of
life to prevent sequelae and complications such as irre-
versible delay in speech and cognitive development.
According to data literature, among prenatal risk factors
(JCIH 2007), family history of HI and TORCH agents
(especially CMV infections) indicated independent risk
factors (P \ 0.00001 and P = 0.024). NICU infants have a
33 % greater chance of developing SNHL, because of the
presence of multiple risk factors (OR = 1.33); in fact, as
the number of coexisting risk factors increases, the prev-
alence of SNHL also increases (r2 = 0.93).
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